Clinical Trial Update: A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

View source ↗

Summary

A completed non-interventional study evaluating whether automated OCT image enrichment with segmentation improves disease activity assessment in neovascular age…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)
• Bevacizumab (bevacizumab)
• Brolucizumab (brolucizumab)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neovascular Age-Related Macular Degeneration | Status: COMPLETED